SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that Chief Executive Officer, Jeb Besser, will present at the Webull Emerging & Innovative Companies Webinar, on Wednesday, October 14, 2026.Webull Emerging & Innovative Companies WebinarPresentation Date and Time: Wednesday, October 14, 2026 at
SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that its Chief Executive Officer, Jeb Besser, will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026.iAccess Alpha Virtual Conference Details: Dates: September 15-16, 2026 Presentation
RALEIGH, NC/ ACCESS Newswire/ September 8, 2026/ iAccess Alpha today announced that it will host its Virtual Best Ideas Fall Investment Conference on September 15-16, 2026, bringing together small and microcap public companies and investors for two days of company presentations and 1 x1 meetings. The conference will begin on Tuesday, September 15, 2026, with a...
SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that it has secured a contract with a national U. pharmacy benefit manager (PBM) in the United States.
Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot CustomizationSAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that the U. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the sy
Modular Medical, Inc. (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system. The update further expands the system’s functionality and provides users with greater flexibility and customization options in bolus dosing, an enhanced user interface (UI), and other software upgrades. In July, the company submitted to the FDA a series of software enhancements to its Pivot insulin delivery syste
* Meet with Modular Medical CEO Jeb Besser. * Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period.
This is the newest page. Registered accounts read further back.